It has been shown that treatment with a small molecule inhibitor of HIF-1α, PX-478, inhibited progression and spread of orthotopic human small cell lung cancer and lung adenocarcinoma in mice [38]. This evidence concerns the gene HIF1A and small cell lung carcinoma.